🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The risk of severe course of SARS-CoV-2 infection in people with Down Syndr...
Status
Unknown
Location
UMC utrecht
Start Date
2021-02-03
Trial ID
NCT05145348
Pregnant people have a higher risk of severe COVID-19 disease. Pregnant peo...
Status
Completed
Location
University of British Columbia
Start Date
2022-06-01
Trial ID
NCT05663762
The goal of this study is to assess serious adverse events associated with ...
Status
Completed
Location
CMIC Co., Ltd
Start Date
2022-11-15
Trial ID
NCT05894590
A Clinical Study to Evaluate the Immunogenicity and Safety of Sequential Im...
Status
Unknown
Location
Zhuhai Peoples' Hospital Medical Group
Start Date
2021-09-30
Trial ID
NCT05125874
Treatments Being Tested
To evaluate the immunogenicity and safety of the third dose SARS-CoV-2 Vacc...
Status
Unknown
Location
Anning First People's Hospital
Start Date
2021-12-18
Trial ID
NCT05163652
Treatments Being Tested
This is a phase 1 study to assess the safety and immunogenicity of differen...
Status
Completed
Location
Josha Research
Start Date
2022-05-30
Trial ID
NCT05228314
This study will collect information on the safety of BNT162b2 products for ...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2022-03-18
Trial ID
NCT05032976
Treatments Being Tested
A Phase 1 study to evaluate safety, tolerability, and immunogenicity of SAR...
Status
Unknown
Location
Dr. Cipto Mangunkusumo Hospital
Start Date
2022-07-08
Trial ID
NCT05434585
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety, and re...
Status
Completed
Location
Pinnacle Research Group-409 E 10th St
Start Date
2023-10-19
Trial ID
NCT06097273
Treatments Being Tested
This study will enroll individuals who have: * Completed primary series of...
Status
Completed
Location
University of California, San Diego
Start Date
2021-12-06
Trial ID
NCT05077254